TMEM41B is a novel regulator of autophagy and lipid mobilization
Francesca Moretti(Novartis (Switzerland)), Beat Nyfeler(Novartis (Switzerland)), Stacie E. Dodgson(Harvard University), Isabelle Claerr(Novartis (Switzerland)), David Marcellin(Novartis (Switzerland)), Christophe Antczak(Novartis (Switzerland)), John Reece-Hoyes(University of Massachusetts Chan Medical School), Kang Zhao, Christel Genoud(University of Lausanne), Débora Bonenfant(Novartis (Switzerland)), Ramnik J. Xavier(Massachusetts General Hospital), Zinger Yang(Broad Institute), Rowena DeJesus(Novartis (United States)), Gregory R. Hoffman, Phil Bergman(Novartis (United States)), Carsten Russ(Broad Institute), Matthias Mueller(Novartis (Switzerland)), Leon O. Murphy(Casma Therapeutics (United States)), Jonathan M. Goodwin(Casma Therapeutics (United States)), Alexandra Graff(Friedrich Miescher Institute), Damien Bégué(Novartis (Switzerland))
Cited by 178
Related Papers
A Draft Sequence of the Neandertal Genome
|Science|2010|4.6k
The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
|Cell Host & Microbe|2014|3.3k
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
|Genome biology|2012|2.8k